Abstract
In a model of ventricular arrhythmias of central origin, we investigated the effects of rilmenidine, an oxazoline with antihypertensive properties, and idazoxan, an imidazoline that is an antagonist of the hypotensive effects of rilmenidine.
Bicuculline, a GABAA receptor antagonist, was administered intracistemally (i.c.) to produce arrhythmias in pentobarbitone anaesthetised rabbits; 10 μg/kg bicuculline i.c. induced polymorphic ventricular ectopic beats and ventricular tachycardia while blood pressure increased by about 50–60% and sinusal heart rate decreased by about 20%. Rilmenidine, either administered intravenously (0.01, 0.1, 1 mg/kg i.v.) or i.c. (3, 10, 30 μg/kg) dose-dependently prevented the occurrence of bicuculline-induced arrhythmias while, because of a lower base-line, the blood pressure values reached were less as compared to controls. Idazoxan administered i.v. (3, 10 mg/kg) had a similar action. Idazoxan i.c. (15 μg/kg) had no significant antiarrhythmic effect but antagonized in part the haemodynamic and antiarrhythmic effects of rilmenidine (1 mg/kg i.v.; 30 μg/kg i.c.).
It is suggested that the antiarrhythmic effects observed with rilmenidine are mainly mediated by blunting the bicuculline-induced increase in the sympathetic nervous output to the heart and the vascular beds. These effects of rilmenidine are likely to originate both from the central and peripheral nervous system. The antiarrhythmic effects of idazoxan i.v. might be related to a blocking action on alpha2-adrenoceptors at the level of the coronary arteries and other vascular beds.
Similar content being viewed by others
References
Baumgart D, Heusch G (1995) Neuronal control of coronary blood flow. Basic Res Cardiol 90:142–159
Bernauer W (1990) Antiarrhythmic and antinecrotic effects of yohimbine stereoisomers in rats during coronary occlusion and reperfusion. Basic Res Cardiol 85:132–141
Chalmers J, Pilowsky P (1991) Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure. J Hypertens 9:675–694
Dabiré H (1986) Idazoxan: a novel pharmacological tool for the study of alpha2-adrenoceptors. J Pharmacol (Paris) 17:113–118
DiMicco JA, Hamilton BL, Gillis RA (1977) Central nervous system sites involved in the cardiovascular effects of picrotoxin. J Pharmacol Exp Ther 203:64–71
Ernsberger P, Collins LA, Graves ME, Dreshaj IA, Haxhiu M (1995) Imidazoline I1 receptors in the ventrolateral medulla and their role in cardiorespiratory control. In: Trouth CO, Millis RM, Kiwull-Schöne HF, Schläfke ME (eds) Ventral brainstem mechanisms and control of respiration and blood pressure. Marcel Dekker, New York, pp 319–358
Feldman J, Tibiriça E, Bricca G, Dontenwill M., Belcourt A, Bousquet P (1990) Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br J Pharmacol 100:600–604
Freedman JE, Aghajanian GK (1984) Idazoxan (RX 781094) selectively antagonizes alpha2-adrenoceptors on rat central neurons. Eur J Pharmacol 105:265–272
Gomez RE, Ernsberger P, Feinland G, Reis DJ (1991) Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur J Pharmacol 195:181–191
Gould L, Reddy CVR, Weinstein T, Gomprecht RF (1975) Antiarrhythmic prophylaxis with phentolamine in acute myocardial infarction. J Clin Pharmacol 15:191–197
Guyenet PG, Lynch KR, Rosin DL, Stornetta RL, Allen AM (1995) Alpha2-adrenergic receptors rather than imidazoline binding sites mediate the sympatholytic effect of clonidine in the rostral ventrolateral medulla. In: Trouth CO, Millis RM, Kiwull-Schöne HF, Schläfke ME (eds) Ventral brainstem mechanisms and control of respiration and blood pressure. Marcel Dekker, New York, pp 281–303
Hannah JAM, Hamilton CA, Reid JL (1983) RX781094, a new potent alpha2 adrenoceptor antagonist: in vivo and in vitro studies in the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 322:221–227
Hayashi Y, Kamibayashi T, Maze M, Yamatodani A, Sumikawa K, Kuro M, Yoshiya I (1993) Role of imidazoline-preferring receptors in the genesis of epinephrine-induced arrhythmias in halothane-anesthetized dogs. Anesthesiology 78:524–530
Heyndrickx GR, Vilaine JP, Moerman EJ, Leusen I (1984) Role of prejunctional alpha2-adrenergic receptors in the regulation of myocardial performance during exercice in conscious dogs. Circ Res 54:683–693
Japundzic N, Grichois ML, Zitoun P, Laude D, Elghozi JL (1990) Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers. J Anton Nerv Syst 30:91–100
Koenig-Berard E, Tierney C, Beau C, Delbarre G, Lhoste F, Labrid C (1988) Cardiovascular and central nervous system effects of rilmenidine in rats. Am J Cardiol 61:22D-31D
Korner PI, Oliver JR, Sleight P, Chalmers JP, Robinson JS (1974) Effects of clonidine on the baroreceptor-heart rate reflex and on single aortic baroreceptor fibre discharge. Eur J Pharmacol 28:189–198
Laubie M, Poignant JC, Scuvee-Moreau J, Dresse A, Schmitt H (1985) Pharmacological properties of (N-dicyclopropyl-methylamino-2-oxazoline (S3341)), an alpha2-adrenoceptor agonist. J Pharmacol (Paris) 16:259–278
Mac Kaigue JP, Harron DWG (1992) The effects of rilmenidine on tests of autonomic function in humans. Clin Pharmacol Ther 52:511–517
Mammoto T, Kamibayashi T, Hayashi Y, Takada K, Yamatodani A, Yoshiya I (1995) Rilmenidine prevents epinephrine induced arrhythmias in halothane anaesthetized dogs. J Cardiovase Pharmacol 26 [Suppl 2]:S40-S43
Reis DJ, Golanov EV, Ruggiero DA, Sun MK (1994) Sympatho-excitatory neurons of the rostral ventrolateral medulla are oxygen sensors and essential elements in the tonic and reflex control of the systemic and cerebral circulations. J Hypertens 12 [Suppl 10]:S159-S180
Roegel JC, De Jong W, Monassier L, Feldman J, Bousquet P (1996) Comparative effects of idazoxan, prazosin and yohimbine on coronary ligation induced arrhythmias in spontaneously hypertensive rats. J Cardiovasc Pharmacol 27:226–234
Segal SA, Pearle DL, Gillis RA (1981) Coronary spasm produced by picrotoxin in cats. Eur J Pharmacol 76:447–451
Segal SA, Thomas J, Gillis RA (1984) Blockade of central nervous system GABAergic tone causes sympathetic-mediated increases in coronary vascular resistance in cats. Circ Res 55:404–415
Seitelberger R, Guth BD, Heusch G, Ross J (1991) Alpha2-adrenergic coronary constriction in ischemic myocardium during exercise. In: Heusch G, Ross J (eds) Adrenergic mechanisms in myocardial ischemia. Steinkopff, Darmstadt, pp 207–217
Skinner JE (1993) Neurocardiology: brain mechanisms underlying fatal cardiac arrhythmias. Neurologic Clinics 11:325–351
Szabo B, Urban R, Starke K (1993) Sympatho-inhibition by rilmenidine in conscious rabbits; involvement of alpha2-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 348:593–600
Thomas GP, Stephen PM (1991) Protective action of clonidine against the arrhythmogenic and lethal effects of ouabain in guinea pigs. Br J Pharmacol 104:995–999
Urban R, Szabo B, Starke K (1995) Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxononidine, rilmenidine and UK 14304. Eur J Pharmacol 282:29–37
Van Giersbergen PLM, Palkovits M, De Jong W (1992) Involvement of neurotransmitters in the nucleus tractus solitarii in cardiovascular regulation. Physiol Rev 72:789–824
Van Zwieten PA, Thoolen MHMC, Jonkman FAM, Willfert B, De Jong A, Timmermans PBMWM (1986) Central and peripheral effects of S3341 [(N-dicyclopropyl-methylamino-2-oxazoline)] in animal models. Arch Int Pharmacodyn Ther 279:130–149
Walker MIA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DWG, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B (1988) The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc Res 22:447–455
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roegel, JC., Yannoulis, N., De Jong, W. et al. Inhibition of centrally induced ventricular arrhythmias by rilmenidine and idazoxan in rabbits. Naunyn-Schmiedeberg's Arch Pharmacol 354, 598–605 (1996). https://doi.org/10.1007/BF00170834
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00170834